Target intelligence / Profile preview

Presynaptic mechanisms controlling acetylcholine release

Molecular classification
Transporter, Enzyme, Ion channel, G protein-coupled receptor, SNARE protein
01

Overview

Presynaptic mechanisms controlling acetylcholine release refer to the integrated physiological processes within the cholinergic nerve terminal that regulate the synthesis, packaging, and exocytosis of acetylcholine (ACh). This pathway begins with the uptake of choline via the high-affinity choline transporter (CHT1) and its subsequent acetylation by choline acetyltransferase (ChAT) (Source: UniProt P28329, P04812). Synthesized ACh is then sequestered into synaptic vesicles by the vesicular acetylcholine transporter (VAChT) (Source: UniProt Q16572). Upon neuronal depolarization, voltage-gated calcium channels (typically P/Q-type) open, triggering the SNARE-mediated fusion of vesicles with the presynaptic membrane to release ACh into the synaptic cleft (Source: PubMed PMID: 15740610). This release is modulated by presynaptic autoreceptors, primarily M2 and M4 muscarinic receptors, which provide inhibitory feedback (Source: StatPearls, Cholinergic Receptors). Dysregulation of these mechanisms is implicated in neurodegenerative diseases like Alzheimer's and neuromuscular disorders such as Lambert-Eaton myasthenic syndrome, making these presynaptic components vital therapeutic targets (Source: PubMed PMID: 21496427).

Other names
Presynaptic cholinergic regulationCholinergic neurotransmission controlPresynaptic ACh release mechanismsCholinergic vesicle cycle
02

Mechanism of action

Modulation of acetylcholine release through inhibition of SNARE-mediated exocytosis, blockade of high-affinity choline uptake, inhibition of vesicular transport, or modulation of presynaptic auto- and heteroreceptors.

03

Biological functions

NeurotransmissionSynaptic vesicle exocytosisCholinergic signalingSynaptic plasticity
04

Disease associations

Alzheimer's diseaseMyasthenia gravisLambert-Eaton myasthenic syndromeBotulismAutonomic neuropathy
05

Safety considerations

Neuromuscular blockadeAutonomic nervous system instabilityCognitive side effectsRespiratory failure
06

Interacting drugs

Botulinum toxin

5 more in the full profile.

07

Biomarkers

Vesicular acetylcholine transporter (VAChT) PET imagingCholine acetyltransferase (ChAT) activityCerebrospinal fluid acetylcholine levelsElectromyography (EMG) jitter analysis

Beyond the preview

Go deeper on Presynaptic mechanisms controlling acetylcholine release.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presynaptic mechanisms controlling acetylcholine release.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call